# European Society for Medical Oncology

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/european-society-for-medical-oncology/

## Facts

| Field | Value |
| --- | --- |
| Country | CH |
| Description | Professional organisation |
| OpenAlex ID | https://openalex.org/F4320324142 |
| ROR ID | https://ror.org/03xtz2n86 |
| Works | 2,709 |

## Funder papers

- [Progression-free survival and safety at 3.5 years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer](https://scholariq.org/papers/progression-free-survival-and-safety-at-3-5-years-of-follow-up-results-from-the/)
- [High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome](https://scholariq.org/papers/high-prevalence-of-somatic-oncogenic-driver-alterations-in-patients-with-nsclc/)
- [Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial](https://scholariq.org/papers/efficacy-and-safety-of-niraparib-in-patients-aged-65-years-and-older-with/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.